Advertisement

Unproven Methods of Diagnostics and Treatment

  • Matjaž Zwitter
Chapter

Abstract

Labels such as holistic approach or integrative medicine are often used to emphasize differences between conventional medicine and unconventional methods of diagnostics and treatment. Yet, such a distinction is not justified as it implies that conventional medicine does not serve the physical, psychological, and spiritual needs of our patients. Both from the scientific and the ethical standpoint, unproven methods of diagnostics are unacceptable. Among therapeutic measures, many complementary methods may benefit the patient. On the other hand, unproven procedures as an alternative to standard treatment of proven efficacy often lead to deterioration of patient’s health and should not be applied by persons with a license of a medical doctor. A similar critical attitude is appropriate also for drugs which are still in an early stage of development. In this case, a clinical trial is the only acceptable option. If we really follow the interests of patients and not those of the pharmaceutical industry, the Right to Try legislation which allows the early use of unapproved drugs for critically ill patients with no standard treatment left is not acceptable.

Keywords

Integrative medicine Alternative diagnostics Supplementary treatment Alternative treatment Right to try 

References

  1. 1.
    Melzer J, Iten F, Hostanska K, Saller R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed. 2009;16:217–26.  https://doi.org/10.1159/000226249.CrossRefPubMedGoogle Scholar
  2. 2.
    Evans M, Bryant S, Huntley AL, Feder G. Cancer Patients’ experiences of using mistletoe (Viscum album): a qualitative systematic review and synthesis. J Altern Complement Med. 2016;22:134–44.  https://doi.org/10.1089/acm.2015.0194.CrossRefPubMedGoogle Scholar
  3. 3.
    Delo newspaper, Ljubljana, December 21, 2015.Google Scholar
  4. 4.
    Rubin MJ, Matthews KR. The impact of right to try laws on medical access in the United States. The Baker institute policy report. 2016;66.Google Scholar

Suggested Reading

  1. Barić H, Đorđević V, Cerovečki I, Trkulja V. Complementary and alternative medicine treatments for generalized anxiety disorder: systematic review and meta-analysis of randomized controlled trials. Adv Ther. 2018;35:261–88.  https://doi.org/10.1007/s12325-018-0680-6.CrossRefPubMedGoogle Scholar
  2. Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C. Complementary and alternative therapies in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:909–36.  https://doi.org/10.1016/j.ncl.2015.07.008.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Carrieri D, Peccatori FA, Boniolo G. The ethical plausibility of the ‘Right to Try’ laws. Crit Rev Oncol Hematol. 2018;122:64–71.  https://doi.org/10.1016/j.critrevonc.2017.12.014.CrossRefPubMedGoogle Scholar
  4. Holbein ME, Berglund JP, Weatherwax K, Gerber DE, Adamo JE. Access to investigational drugs: FDA expanded access programs or “Right-to-Try” legislation? Clin Transl Sci. 2015;8:526–32.  https://doi.org/10.1111/cts.12255.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Mullins-Owens H. Integrative health services: ethics, law, and policy for the new public health workforce. Berlin: Springer; 2016. ISBN-13: 978-3319298559.CrossRefGoogle Scholar
  6. Sandman L, Liliemark J. From evidence-based to hope-based medicine? Ethical aspects on conditional market authorization of and early access to new cancer drugs. Semin Cancer Biol. 2017;45:58–63.  https://doi.org/10.1016/j.semcancer.2017.05.009.CrossRefPubMedGoogle Scholar
  7. Stuttaford M, Al Makhamreh S, Coomans F, Harrington J, Himonga C, Hundt GL. The right to traditional, complementary, and alternative health care. Glob Health Action. 2014;7:24121.  https://doi.org/10.3402/gha.v7.24121.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Matjaž Zwitter
    • 1
    • 2
  1. 1.Faculty of MedicineUniversity of MariborMariborSlovenia
  2. 2.Institute of OncologyLjubljanaSlovenia

Personalised recommendations